PRECISION BIOSCIENCES INC Current Assets
PRECISION BIOSCIENCES INC (DTIL) had Current Assets of $91.55 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $91.55M.
- 2026-03-31: Assets, Current $108.69M.
- 2025-12-31: Assets, Current $118.74M.
- 2025-09-30: Assets, Current $51.70M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $91.55M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $108.69M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $118.74M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $51.70M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $70.26M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $82.10M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $94.99M 10-K · filed 2026-03-12 |
| 2024-09-30 | $110.52M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $144.03M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $160.83M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $136.36M 10-K · filed 2025-03-26 |
| 2023-09-30 | $145.85M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $147.86M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $169.02M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $199.10M 10-K · filed 2024-03-27 |
| 2022-09-30 | $225.37M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $247.69M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $134.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $161.75M 10-K · filed 2023-03-09 |
| 2021-09-30 | $183.05M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $188.30M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $219.14M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $105.56M 10-K · filed 2022-03-15 |
| 2020-09-30 | $122.56M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $137.39M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $166.84M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $193.67M 10-K · filed 2021-03-18 |
| 2019-09-30 | $219.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $237.09M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $136.98M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $115.67M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |